Reference Rights Sample Clauses

Reference Rights. Cara (and its Affiliates and Sub-Licensees) shall have (i) the right of reference to the Enteris DMF and the information therein, and (ii) the right to reference the information contained in the Enteris DMF in all of Cara’s (and its Affiliates and Sub-Licensees) Regulatory Filings in jurisdictions where the Enteris DMF is not recognized, in each case solely for the purpose of exercising, using and practicing the licenses and other rights granted to Cara pursuant to this Agreement, provided that Cara shall bear any expenses (including expenses of Enteris) in respect of exercising any such right of reference.
AutoNDA by SimpleDocs
Reference Rights. Customer agrees to serve as a reference that will, upon Xxxx's reasonable request, (i) provide comments related to this Agreement for distribution to third parties, and (ii) participate in Product related case studies. Snow shall have the right to issue a press release or other public statement concerning this Agreement and the relationship of the parties. Customer grants Snow the right to use Customer’s name and logo in Snow’s marketing communications and materials, subject to Customer’s published trademark guidelines and policies.
Reference Rights. (a) Subject to Section 4.03(f), each Party hereby grants to the other Party (and their respective sublicensees or designees) a right of reference to Regulatory Filings owned or controlled by such Party as reasonably necessary to support the other Party's Regulatory Filings made for the following purposes: (1) for MYLAN to Develop, manufacture and Commercialize Licensed Products in the Field in the Territory in accordance with this Agreement, including conducting any bridge programs to support a change in manufacturer and (2) for THERAVANCE to (w) Develop Licensed Products in the Field in the Territory in accordance with this Agreement, (x) file the initial NDA to Commercialize the first Licensed Products in the Field in the U.S. in accordance with this Agreement, (y) Commercialize Licensed Product in the Field in the U.S. under the Co-Promotion Agreement, and (z) Develop, manufacture and Commercialize Licensed ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. ​ Products (i) in the Field in China and the Reverted Countries and (ii) outside of the Field worldwide. Such rights of reference may include:
Reference Rights. 4.1 The Supplier has the right to use the Customer’s name and logo for reference purposes unless otherwise agreed in writing.
Reference Rights. Each Party (the “Sponsoring Party”) hereby grants the other Party (the “Referencing Party”) a right of reference to all data and information contained or referenced in those sections of Regulatory Filings for the Sponsoring Party’s (and in the case of Schering, its Affiliates’) Products in the Territory (Licensed Products in the case of Schering, and Prescription Products bearing the Santarus Marks in the case of Santarus) that would be reasonably necessary for the Referencing Party’s Regulatory Filings concerning Licensed Products for Licensed Indications in the Field in the Territory (in the case of Schering as the Referencing Party) or Prescription Products bearing the Santarus Marks in the Territory (in the case of Santarus as the Referencing Party). The Sponsoring Party shall provide the applicable Regulatory Authority a letter confirming this right of reference at any time within fifteen (15) days of the Referencing Party’s request and shall take such other actions and execute such other documents as the Referencing Party may reasonably request to further confirm and give effect to this right of reference. Additionally, the Sponsoring Party agrees that the Referencing Party shall have the right, subject to JSC approval, to add to the Sponsoring Party’s applicable Regulatory Filing in the Territory protocols for clinical trials that may be required for Marketing Approval of (a) a Licensed Product for Licensed Indications in the Field by a Regulatory Authority in the Territory, in the case of Schering as the Referencing Party or (ii) a Prescription Product in the Territory, in the case of Santarus as the Referencing Party.
Reference Rights. Each Party shall have the right, free of ---------------- charge, to refer to, access, cross reference, and use in their respective territories (i) information and Data provided by the other Party pursuant to Section 3.2.2 and generated by the other Party in the development and clinical testing of the Compound and the Product, and (ii) documents relating to the Product and the Finished Product filed by the other Party, its Affiliates or its Sublicensees with regulatory entities in their respective territories with respect to activities conducted in connection with development, approval and sale of the Product and the Finished Product, including, without limitation, the clinical studies and other supporting information, and any written communications to and with the FDA (or counterpart agency), provided that any out-of-pocket expenses incurred by the providing Party related to the provision of copies of such information, Data or documents required to the accessing Party shall be borne by the accessing Party. It is understood and agreed by the Parties that CTIT shall have the right, free of charge, to refer to, access, cross reference and use any such documents and information and Data prepared and/or filed by Chugai, its Affiliates, or its Sublicensees with respect to the Compound, the Product and/or the Finished Product. It is understood and agreed by the Parties that Chugai shall have the right, free of charge, to refer to, access, cross reference and use any such documents and information and Data prepared and/or filed by CTIT in any country outside of the Territory with respect to the Compound and/or the Product, and to receive a written right of reference for filing with regulatory authorities, to obtain regulatory approval of the Finished Product in the Territory.
Reference Rights. BSC and the Company shall each have reference rights to the other Party’s DMF filed at the FDA with respect to Products and Injection Catheters.
AutoNDA by SimpleDocs
Reference Rights. Each party shall have the right, free of charge, to use any information and data provided by the other Party pursuant to Section 6.3, including, without limitation, data and information generated by the other Party or Party's Affiliates in the development and clinical testing of the Product as follows in this Section 6.4. It is understood and agreed by the Parties that ISTA and its licensees outside the Territory shall have the right, free of charge, to refer to, access, cross reference and use all clinical information and data filed with regulatory agencies in the Territory (including, without limitation, all communications between Otsuka or those acting on behalf of Otsuka, and such regulatory authorities concerning the Product) by or on behalf of Otsuka or its Sublicensee with respect to the Product. It is understood and agreed by the Parties that Otsuka shall have the right, free of charge, to refer to, access, cross reference and use all clinical information and data filed with regulatory agencies outside the Territory (including, without limitation, all communications between ISTA or those acting on behalf of ISTA, and such regulatory authorities concerning the clinical information and data for the Product) by or on behalf of ISTA (including by ISTA's licensees outside the Territory) with respect to the Product for indications within the Field in support of Otsuka's Regulatory Filings in the Territory.
Reference Rights. Following the Closing and in perpetuity the Purchaser shall permit the Seller to reference (and upon request shall so advise the FDA or other applicable regulatory authority), and upon Seller's request shall accord Seller access to, and copies of, all data contained in the Purchaser's Regulatory Approvals for the Royalty Bearing Products (as defined in the License Agreement) to the extent necessary to permit Seller to market and distribute the Royalty Bearing Products outside the Territory and to obtain and maintain Regulatory Approvals to market and distribute the Royalty Bearing Products outside the Territory. Purchaser shall promptly advise Seller of any changes made in any Royalty Bearing Product Regulatory Approval that could reasonably be expected to have an impact on such Regulatory Approvals of Seller outside the Territory.

Related to Reference Rights

  • Relative Rights This Article 10 defines the relative rights of Holders of Notes and holders of Senior Debt. Nothing in this Indenture shall:

  • Cumulative Rights All agreements, warranties, guaranties, indemnities and other undertakings of Obligors under the Loan Documents are cumulative and not in derogation of each other. The rights and remedies of Agent and Lenders under the Loan Documents are cumulative, may be exercised at any time and from time to time, concurrently or in any order, and are not exclusive of any other rights or remedies available by agreement, by law, at equity or otherwise. All such rights and remedies shall continue in full force and effect until Full Payment of all Obligations.

  • Waiver; Cumulative Rights The failure or delay of either party to require performance by the other party of any provision hereof shall not affect its right to require performance of such provision unless and until such performance has been waived in writing. Each and every right hereunder is cumulative and may be exercised in part or in whole from time to time.

  • Cumulative Rights and No Waiver Each and every right granted to a party hereunder or under any other document delivered hereunder or in connection herewith, or allowed it by law or equity, shall be cumulative and may be exercised from time to time. No failure on the part of a party to exercise, and no delay in exercising, any right will operate as a waiver thereof, nor will any single or partial exercise by a party of any right preclude any other or future exercise thereof or the exercise of any other right.

  • Cumulative Rights; No Waiver The rights, powers and remedies of the Administrative Agent and the Lenders hereunder and under the other Loan Documents are cumulative and in addition to all rights, power and remedies provided under any and all agreements among the Borrower Parties, the Administrative Agent and the Lenders relating hereto, at law, in equity or otherwise. Any delay or failure by Administrative Agent and the Lenders to exercise any right, power or remedy shall not constitute a waiver thereof by the Administrative Agent or the Lenders, and no single or partial exercise by the Administrative Agent or the Lenders of any right, power or remedy shall preclude other or further exercise thereof or any exercise of any other rights, powers or remedies.

  • NO WAIVER; CUMULATIVE RIGHTS No failure on the part of the Guaranteed Party to exercise, and no delay in exercising, any right, remedy or power hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by the Guaranteed Party of any right, remedy or power hereunder preclude any other or future exercise of any right, remedy or power hereunder. Each and every right, remedy and power hereby granted to the Guaranteed Party or allowed it by Law shall be cumulative and not exclusive of any other, and may be exercised by the Guaranteed Party at any time or from time to time. The Guaranteed Party shall not have any obligation to proceed at any time or in any manner against, or exhaust any or all of the Guaranteed Party’s rights against, Parent or any other person (including any Other Guarantor) liable for any of the Obligations prior to proceeding against the Guarantor hereunder, and the failure by the Guaranteed Party to pursue rights or remedies against Parent or Merger Sub (or any Other Guarantor) shall not relieve the Guarantor of any liability hereunder, and shall not impair or affect the rights and remedies, whether express, implied or available as a matter of Law, of the Guaranteed Party.

  • Cumulative Rights, etc The rights, powers and remedies of Secured Party under this Agreement shall be in addition to all rights, powers and remedies given to Secured Party by virtue of any applicable law, rule or regulation of any governmental authority, or the Note, all of which rights, powers, and remedies shall be cumulative and may be exercised successively or concurrently without impairing Secured Party’s rights hereunder. Debtor waives any right to require Secured Party to proceed against any person or entity or to exhaust any Collateral or to pursue any remedy in Secured Party’s power.

  • Cumulative Rights and Remedies The rights and remedies provided in this Agreement and all other rights and remedies available to either Party at law or in equity are, to the extent permitted by law, cumulative and not exclusive of any other right or remedy now or hereafter available at law or in equity. Neither asserting a right nor employing a remedy shall preclude the concurrent assertion of any other right or employment of any other remedy, nor shall the failure to assert any right or remedy constitute a waiver of that right or remedy.

  • Provisions Define Relative Rights This Agreement is intended solely for the purpose of defining the relative rights of the Issuer on the one hand and the Subordinated Lenders and the Subordinated Borrowers on the other, and no other Person shall have any right, benefit or other interest under this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.